MSA CenterS of excellence

Publications

Our Centers of Excellence are at the heart of MSA research, conducting studies that shape the future of diagnosis, care, and treatment. This work represents the dedication of scientists, clinicians, and patients working together to change the future of MSA.

Filter by:

Center of Excellence

















Topic










Multiple System Atrophy: Pathology, Pathogenesis, and Path Forward

Multiple system atrophy (MSA) is a rare but fatal brain disease that causes problems with movement and automatic body functions, like blood pressure control. Scientists have found that MSA involves a unique buildup of a protein called α-synuclein, and they are exploring whether changes in brain cells or the immune system may be the main cause, with new research bringing hope for better understanding and future treatments.

MSA Center of Excellence:

Brigham and Women’s Hospital

Multiple system atrophy: advances in pathophysiology, diagnosis, and treatment

Multiple system atrophy (MSA) is a rare, progressive brain disease that causes a mix of movement and non-movement symptoms, often making it hard to distinguish from similar conditions like Parkinson’s disease. Recent research has shed light on how MSA develops, leading to updated diagnostic criteria and opening new possibilities for earlier detection and the development of treatments that could slow the disease.

MSA Center of Excellence:

Medizinische Universitaet Innsbruck

How Do I Diagnose Multiple System Atrophy-A Videolibrary on Clinical and Imaging Features

The aim of this “How Do I” video project is to support clinicians in using the MDS-MSA criteria by showing videos for each feature of the criteria.

MSA Center of Excellence:

NYU Dysautonomia Center – NYU Langone Health, Medizinische Universitaet Innsbruck, Brigham and Women’s Hospital, Mayo Clinic

Early Screening for the Parkinson Variant of Multiple System Atrophy: A 6-Item Score

We validated and improved a 4-item MSA-P score to distinguish early MSA-P from Parkinson’s disease. Expanding it to a 6-item score achieved 89% sensitivity and 98% specificity, providing a cost-effective tool for early-stage MSA-P identification.

MSA Center of Excellence:

Tel Aviv Medical Center

Biomarkers of neurodegenerative parkinsonisms: From current clinical to future biological definitions – literature review and our experience.

In this article we review evidence on imaging and lab biomarkers of degenerative parkinsonisms including MSA and provide examples from our imaging unit and our research lab.

MSA Center of Excellence:

Hospital Clinic de Barcelona